Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution

Conditions

• Open-Angle Glaucoma
• Ocular Hypertension

Interventions

• DRUG: Brinzolamide 1%/Timolol maleate 0.5% fixed combination ophthalmic suspension
• DRUG: Dorzolamide hydrochloride 1%/Timolol maleate 0.5% ophthalmic solution
• DRUG: Subject's habitual PGA monotherapy

Sponsor

Alcon, a Novartis Company